IGF-I signalling in bone growth: Inhibitory actions of dexamethasone and IL-1β

Growth Hormone and IGF Research

Volumn 17, Issue 5, 2007, Pages 435-439

  MacRae, Vicky E ^a,b   Ahmed, S Faisal ^b   Mushtaq, Talat ^a,b   Farquharson, Colin ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Cytokines; Glucocorticoids; Growth plate; Insulin like growth factor I

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 1BETA; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE GROWTH; CARTILAGE CELL; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FETUS; GROWTH INHIBITION; HORMONAL REGULATION; METATARSAL BONE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE CULTURE;

ANIMALS; BONE DEVELOPMENT; CELL LINE; CHONDROCYTES; DEXAMETHASONE; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-1BETA; METATARSAL BONES; MICE; ORGAN CULTURE TECHNIQUES; SIGNAL TRANSDUCTION;

EID: 34548245970     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.05.002     Document Type: Article

References (25)

1. Mushtaq T., and Ahmed S.F. The impact of corticosteroids on growth and bone health. Arch. Dis. Child. 87 (2002) 93-96
2. MacRae V.E., Wong S.C., Farquharson C., and Ahmed S.F. Cytokine actions in growth disorders associated with pediatric chronic inflammatory diseases. Int. J. Mol. Med. 18 (2006) 1011-1018
3. DeBenedetti F., Alonzi T., Moretta A., et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I - A model for stunted growth in children with chronic inflammation. J. Clin. Invest. 99 (1997) 643-650
4. Martensson K., Chrysis D., and Savendahl L. Interleukin-1 beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. J. Bone Miner. Res. 19 (2004) 1805-1812
5. MacRae V.E., Farquharson C., and Ahmed S.F. The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. J. Endocrinol. 189 (2006) 319-328
6. Ahmed S.F., Tucker P., Mushtaq T., Wallace A.M., Williams D.M., and Hughes I.A. Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone. Clin. Endocrinol. 57 (2002) 185-191
7. Mushtaq T., Bijman P., Ahmed S.F., and Farquharson C. Insulin-like growth factor-I augments chondrocyte hypertrophy and reverses glucocorticoid-mediated growth retardation in fetal mice metatarsal cultures. Endocrinology 145 (2004) 2478-2486
8. Wang J., Zhou J., Cheng C.M., Kopchick J.J., and Bondy C.A. Evidence supporting dual, IGF-I-independent and IGF-I-dependent, roles for GH in promoting longitudinal bone growth. J. Endocrinol. 180 (2004) 247-255
9. LeRoith D. Insulin-like growth factor I receptor signalling - overlapping or redundant pathways?. Endocrinology 141 (2000) 1287-1288
10. Petley T., Graff K., Jiang W., Yang H., and Florini J. Variation among cell types in the signaling pathways by which IGF-I stimulates specific cellular responses. Horm. Metab. Res. 31 (1999) 70-76
11. Koike M., Yamanaka Y., Inoue M., Tanaka H., Nishimura R., and Seino Y. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK. J. Bone Miner. Res. 18 (2003) 2043-2051
12. Gioeli D., Black B.E., Gordon V., et al. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization. Mol. Endocrinol. 20 (2006) 503-515
13. Kim I.J., Drahushuk K.M., Kim W.Y., et al. Extracellular signal-regulated kinases regulate dendritic growth in rat sympathetic neurons. J. Neurosci. 24 (2004) 3304-3312
14. Akiyama M., Hideshima T., Hayashi T., et al. Cytokines modulate telomerase activity in a human multiple myeloma cell line. Cancer Res. 62 (2002) 3876-3882
15. Atsumi T., Miwa Y., Kimata K., and Ikawa Y. A chondrogenic cell-line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ. Dev. 30 (1990) 109-116
16. Barancik M., Bohacova V., Sedlak J., Sulova Z., and Breier A. LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance. Eur. J. Pharm. Sci. 29 (2006) 426-434
17. Alessi D.R., Cuenda A., Cohen P., Dudley D.T., and Saltiel A.R. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270 (1995) 27489-27494
18. Kuemmerle J.F., and Bushman T.L. IGF-I stimulates intestinal muscle cell growth by activating distinct PI 3-kinase and MAP kinase pathways. Am. J. Physiol. 275 (1998) G151-G158
19. Fujita T., Fukuyama R., Enomoto H., and Komori T. Dexamethasone inhibits insulin-induced chondrogenesis of ATDC5 cells by preventing PI3K-Akt signaling and DNA binding of Runx2. J. Cell Biochem. 93 (2004) 374-383
20. Giorgino F., Pedrini M.T., Matera L., and Smith R.J. Specific increase in p85alpha expression in response to dexamethasone is associated with inhibition of insulin-like growth factor-I stimulated phosphatidylinositol 3-kinase activity in cultured muscle cells. J. Biol. Chem. 272 (1997) 7455-7463
21. Shen W.H., Jackson S.T., Broussard S.R., et al. IL-1beta suppresses prolonged Akt activation and expression of E2F-1 and cyclin A in breast cancer cells. J. Immunol. 172 (2004) 7272-7281
22. Chen T.L., Mallory J.B., and Hintz R.L. Dexamethasone and 1,25(OH)2 vitamin D3 modulate the synthesis of insulin-like growth factor-I in osteoblast-like cells. Calcified Tissue Int. 48 (1991) 278-282
23. Neuvians T.P., Pfaffl M.W., Berisha B., and Schams D. The mRNA expression of insulin receptor isoforms (IR-A and IR-B) and IGFR-2 in the bovine corpus luteum during the estrous cycle, pregnancy, and induced luteolysis. Endocrine 22 (2003) 93-100
24. Massicotte F., Fernandes J.C., Martel-Pelletier J., Pelletier J.P., and Lajeunesse D. Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts. Bone 38 (2006) 333-341
25. Seckl J.R. 11beta-hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr. Opin. Pharmacol. 4 (2004) 597-602